|
US4844732A
(en)
|
1985-10-24 |
1989-07-04 |
Daicel Chemical Industries Ltd. |
Pyridine-3-carboxamide derivatives
|
|
JPH075555B2
(ja)
|
1986-02-25 |
1995-01-25 |
ダイセル化学工業株式会社 |
ピリドン−3−カルボキサミドの製法
|
|
JPH075554B2
(ja)
|
1986-02-25 |
1995-01-25 |
ダイセル化学工業株式会社 |
5−ブロモピリドン−3−カルボキサミド化合物の製法
|
|
AU6062590A
(en)
|
1989-07-07 |
1991-02-06 |
Schering Corporation |
Pharmaceutically active compounds
|
|
US5304121A
(en)
|
1990-12-28 |
1994-04-19 |
Boston Scientific Corporation |
Drug delivery system making use of a hydrogel polymer coating
|
|
MY106399A
(en)
|
1990-07-24 |
1995-05-30 |
Pfizer |
Cephalosporins and homologeus, preparation and pharmaceutical composition
|
|
FR2665440B1
(fr)
|
1990-07-31 |
1994-02-04 |
Lipha |
Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant.
|
|
JPH05107574A
(ja)
|
1991-03-12 |
1993-04-30 |
Mitsui Petrochem Ind Ltd |
有機非線形光学材料
|
|
WO1993000313A2
(en)
|
1991-06-27 |
1993-01-07 |
Virginia Commonwealth University |
Sigma receptor ligands and the use thereof
|
|
US5356897A
(en)
|
1991-09-09 |
1994-10-18 |
Fujisawa Pharmaceutical Co., Ltd. |
3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
|
|
IT1254134B
(it)
|
1992-01-16 |
1995-09-08 |
Angeletti P Ist Richerche Bio |
Oligonucleotidi antisenso chimicamente modificati.
|
|
IT1254469B
(it)
|
1992-02-25 |
1995-09-25 |
Recordati Chem Pharm |
Derivati benzopiranici e benzotiopiranici
|
|
EP0558245A1
(en)
|
1992-02-25 |
1993-09-01 |
RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY |
Heterobicyclic compounds as antagogists of alpha-1 adrenergic and SHT1A receptors
|
|
AU675680B2
(en)
|
1992-10-14 |
1997-02-13 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
US5994341A
(en)
|
1993-07-19 |
1999-11-30 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic Compositions and methods for the treatment of arthritis
|
|
US6099562A
(en)
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
|
GB2300856A
(en)
|
1995-05-16 |
1996-11-20 |
Pfizer Ltd |
Beta-lactam preparation
|
|
JP3964478B2
(ja)
|
1995-06-30 |
2007-08-22 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬
|
|
AU4153496A
(en)
|
1995-10-20 |
1997-05-07 |
Flora Inc. |
Transdermal delivery of alpha adrenoceptor blocking agents
|
|
WO1997027852A1
(en)
|
1996-01-30 |
1997-08-07 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5968965A
(en)
|
1996-01-30 |
1999-10-19 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
FR2746309B1
(fr)
|
1996-03-22 |
1998-04-17 |
Oreal |
Composition de teinture des fibres keratiniques contenant des pyrazolopyrimidineoxo ; leur utilisation pour la teinture comme coupleurs, procedes de teinture
|
|
PT1027359E
(pt)
|
1996-10-16 |
2003-09-30 |
Ribapharm Inc |
L-nucleosideos monociclicos analogos e suas utilizacoes
|
|
JP2001503414A
(ja)
|
1996-10-31 |
2001-03-13 |
ハーバー ブランチ オーシャノグラフィック インスティテューション インク. |
抗神経性炎症化合物および組成物ならびにその使用法
|
|
JPH10213820A
(ja)
|
1997-01-31 |
1998-08-11 |
Canon Inc |
液晶素子及び液晶装置
|
|
US5942508A
(en)
|
1997-02-04 |
1999-08-24 |
Senju Pharmaceutical Co., Ltd. |
Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid
|
|
EP1025857A4
(en)
|
1997-10-22 |
2003-11-12 |
Eisai Co Ltd |
RETINOIC ACID AGONISTS, PREVENTIVE AND THERAPEUTIC AGENTS FOR NEPHRITES
|
|
US6150379A
(en)
|
1997-11-26 |
2000-11-21 |
Axys Pharmaceuticals, Inc. |
Compounds and compositions as anticoagulants
|
|
BR9914207A
(pt)
|
1998-09-30 |
2001-07-03 |
Procter & Gamble |
Ceto-amidas 2-substituìdas
|
|
AU1230100A
(en)
|
1998-10-29 |
2000-05-22 |
Merck & Co., Inc. |
A method of treating endometriosis
|
|
DE60027420T2
(de)
|
1999-04-28 |
2006-11-16 |
Aventis Pharma Deutschland Gmbh |
Tri-aryl-säurederivate als ppar rezeptor liganden
|
|
AU6903200A
(en)
|
1999-08-16 |
2001-03-13 |
Merck & Co., Inc. |
Heterocycle amides as cell adhesion inhibitors
|
|
BR0014078A
(pt)
|
1999-09-17 |
2002-12-31 |
Millennium Pharm Inc |
Inibidores de fator xa
|
|
JP4744050B2
(ja)
|
1999-09-17 |
2011-08-10 |
ミレニアム・ファーマシューティカルズ・インコーポレイテッド |
ベンズアミドおよび関連するXa因子阻害剤
|
|
PL357083A1
(en)
|
1999-10-29 |
2004-07-12 |
Pfizer Products Inc. |
Hygromycin derivatives
|
|
ES2259617T3
(es)
|
1999-11-05 |
2006-10-16 |
Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) |
Compuestos heterociclicos y su aplicacion como medicamentos.
|
|
TWI284639B
(en)
|
2000-01-24 |
2007-08-01 |
Shionogi & Co |
A compound having thrombopoietin receptor agonistic effect
|
|
US6376515B2
(en)
|
2000-02-29 |
2002-04-23 |
Cor Therapeutics, Inc. |
Benzamides and related inhibitors of factor Xa
|
|
CA2402315A1
(en)
|
2000-03-09 |
2001-09-13 |
Michael Jaye |
Therapeutic uses of ppar mediators
|
|
JP5209835B2
(ja)
|
2000-07-10 |
2013-06-12 |
ヴァーテックス ファーマシューティカルズ (サンディエゴ)エルエルシー |
イオンチャネルアッセイ法
|
|
CA2419966A1
(en)
|
2000-09-06 |
2002-03-14 |
Neurogen Corporation |
Aryl substituted tetrahydroindazoles and their use as ligands for the gaba-a receptor
|
|
EP1404680A2
(en)
|
2000-10-24 |
2004-04-07 |
Glaxo Group Limited |
Process for preparing intermediates of hiv protease inhibitors
|
|
CA2427750C
(en)
|
2000-11-04 |
2011-01-04 |
Aventis Pharma Limited |
Substituted alkanoic acids
|
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
|
EP1353913A2
(en)
|
2001-01-16 |
2003-10-22 |
AstraZeneca AB |
Therapeutic heterocyclic compounds
|
|
CN100352808C
(zh)
|
2001-03-05 |
2007-12-05 |
杜邦公司 |
杂环二酰胺无脊椎害虫控制剂
|
|
CA2443697A1
(en)
|
2001-04-13 |
2002-10-24 |
Pier F. Cirillo |
1,4-disubstituted benzo-fused compounds
|
|
JP2003034671A
(ja)
|
2001-05-17 |
2003-02-07 |
Nippon Nohyaku Co Ltd |
ベンズアミド誘導体及び農園芸用薬剤並びにその使用方法
|
|
US20030175950A1
(en)
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
|
WO2003070912A2
(en)
|
2001-06-06 |
2003-08-28 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
WO2003000245A1
(en)
|
2001-06-22 |
2003-01-03 |
Poseidon Pharmaceuticals A/S |
Compounds for use in disorders associated with mast cell or basophil activity
|
|
CN101357914A
(zh)
|
2001-09-21 |
2009-02-04 |
百时美施贵宝公司 |
含有内酰胺的化合物及其衍生物作为Xa因子的抑制剂
|
|
FR2831536A1
(fr)
|
2001-10-26 |
2003-05-02 |
Aventis Pharma Sa |
Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
|
|
SE0103648D0
(sv)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic quinolone compounds
|
|
HUP0501067A2
(en)
|
2001-11-14 |
2006-02-28 |
Teva Pharma |
Amorphous and crystalline forms of losartan potassium and process for their preparation
|
|
JP2005510564A
(ja)
|
2001-11-28 |
2005-04-21 |
藤沢薬品工業株式会社 |
アポリポタンパク質b阻害剤としての複素環式アミド化合物
|
|
AU2002350217A1
(en)
|
2001-12-04 |
2003-06-17 |
Bristol-Myers Squibb Company |
Glycinamides as factor xa inhibitors
|
|
WO2003062221A1
(en)
|
2002-01-22 |
2003-07-31 |
E.I. Du Pont De Nemours And Company |
Diamide invertebrate pest control agents
|
|
EP1336602A1
(en)
|
2002-02-13 |
2003-08-20 |
Giovanni Scaramuzzino |
Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
|
|
JP4164031B2
(ja)
|
2002-02-14 |
2008-10-08 |
ファルマシア コーポレーション |
P38mapキナーゼのモジュレータとしての置換されたピリジノン
|
|
ES2292937T3
(es)
|
2002-02-21 |
2008-03-16 |
Eli Lilly And Company |
Moduladores para el receptor activado por el proliferador de peroxisomas.
|
|
RU2004128943A
(ru)
|
2002-02-28 |
2005-04-20 |
Байота, Инк. (Us) |
Средства, имитирующие нуклеотиды, и их пролекарственные формы
|
|
US7622592B2
(en)
|
2002-11-01 |
2009-11-24 |
Merck & Co., Inc. |
Carbonylamino-benzimidazole derivatives as androgen receptor modulators
|
|
EP1581539A4
(en)
|
2003-01-03 |
2007-09-19 |
Bristol Myers Squibb Co |
NEW TYROSINE KINASE HEMMER
|
|
ES2387803T3
(es)
|
2003-01-08 |
2012-10-02 |
Novartis Vaccines And Diagnostics, Inc. |
Agentes antibacterianos
|
|
US7122557B2
(en)
|
2003-03-18 |
2006-10-17 |
Bristol-Myers Squibb Company |
Sulfonyl-amidino-containing and tetrahydropyrimidino-containing compounds as factor Xa inhibitors
|
|
JP4742029B2
(ja)
|
2003-04-01 |
2011-08-10 |
アクティブクス バイオサイエンシズ、インコーポレイテッド |
アシル−リン酸及びホスホン酸プローブ並びにその合成方法並びにプロテオーム分析における使用
|
|
EP1613261A4
(en)
|
2003-04-09 |
2011-01-26 |
Novo Nordisk As |
INTRA-CELLULAR FORMATION OF PEPTIDE CONJUGATES
|
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
|
ATE439837T1
(de)
|
2003-06-03 |
2009-09-15 |
Novartis Ag |
5-gliedrige heterocyclische p-38 inhibitoren
|
|
GB0315111D0
(en)
|
2003-06-27 |
2003-07-30 |
Cancer Rec Tech Ltd |
Substituted 5-membered ring compounds and their use
|
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
|
WO2005013914A2
(en)
|
2003-08-08 |
2005-02-17 |
Vertex Pharmaceuticals Incorporated |
Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
|
|
BRPI0413684A
(pt)
|
2003-08-21 |
2006-10-24 |
Univ Griffith |
compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos
|
|
EP1664071A1
(en)
|
2003-08-21 |
2006-06-07 |
Griffith University |
Novel sulfenamide oxides
|
|
CA2537114C
(en)
|
2003-08-27 |
2012-10-02 |
Biota, Inc. |
Tricyclic nucleosides or nucleotides as therapeutic agents
|
|
EP1669348A4
(en)
|
2003-09-30 |
2009-03-11 |
Eisai R&D Man Co Ltd |
NEW ANTIPILIC AGENT CONTAINING A HETEROCYCLIC COMPOUND
|
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
|
JP4526801B2
(ja)
|
2003-11-13 |
2010-08-18 |
新日鐵化学株式会社 |
複素環化合物の製造方法
|
|
EP1532980A1
(en)
|
2003-11-24 |
2005-05-25 |
Novo Nordisk A/S |
N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
|
|
BRPI0416909A
(pt)
|
2003-11-25 |
2007-01-16 |
Pfizer Prod Inc |
método de tratamento de aterosclerose
|
|
BRPI0513717A
(pt)
|
2004-07-23 |
2008-05-13 |
Pfizer |
derivados de piridina
|
|
AU2005274681A1
(en)
|
2004-08-16 |
2006-02-23 |
Verva Pharmaceuticals Pty Ltd |
Metabolism-modulating agents and uses therefor
|
|
MX2007002582A
(es)
|
2004-09-02 |
2008-01-14 |
Vertex Pharma |
Quinazolinas utiles como moduladores de canales ionicos.
|
|
WO2006094347A1
(en)
|
2005-03-08 |
2006-09-14 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
|
US8461128B2
(en)
|
2005-04-15 |
2013-06-11 |
Sloan-Kettering Institute For Cancer Research |
Anti-microbial agents and uses thereof
|
|
KR20080015433A
(ko)
|
2005-05-09 |
2008-02-19 |
버텍스 파마슈티칼스 인코포레이티드 |
바이아릴 우레아 및 이의 유사체의 제조 방법
|
|
WO2006124780A2
(en)
|
2005-05-12 |
2006-11-23 |
Kalypsys, Inc. |
Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase
|
|
GB0510141D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B3
|
|
JP5112297B2
(ja)
|
2005-05-20 |
2013-01-09 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
イオンチャネルのモジュレーターとして有用なキノリン誘導体
|
|
WO2006130493A2
(en)
|
2005-05-31 |
2006-12-07 |
Vertex Pharmaceuticals Incorporated |
Heterocycles useful as modulators of ion channels
|
|
JP2007056213A
(ja)
|
2005-08-26 |
2007-03-08 |
Fujifilm Corp |
焼結含油軸受油用組成物、並びにそれを用いた軸受け装置及び摺動部材
|
|
CA2626641A1
(en)
|
2005-10-21 |
2007-07-19 |
Glaxo Group Limited |
Compounds
|
|
WO2007052843A1
(ja)
|
2005-11-04 |
2007-05-10 |
Takeda Pharmaceutical Company Limited |
複素環アミド化合物およびその用途
|
|
WO2007081966A2
(en)
|
2006-01-09 |
2007-07-19 |
University Of Southern California |
Small molecules for treating cancer and abnormal cell proliferation disorders
|
|
UY30118A1
(es)
|
2006-01-31 |
2007-06-29 |
Tanabe Seiyaku Co |
Compueto amina trisustituido
|
|
WO2007095187A2
(en)
|
2006-02-13 |
2007-08-23 |
Trustees Of Boston University |
Compositions and methods for antibiotic potentiation and drug discovery
|
|
AR059826A1
(es)
|
2006-03-13 |
2008-04-30 |
Univ California |
Inhibidores de urea conformacionalmente restringidos de epoxido hidrolasa soluble
|
|
US7480400B2
(en)
|
2006-03-16 |
2009-01-20 |
Siemens Medical Solutions Usa, Inc. |
Detection of fiber pathways
|
|
US8841483B2
(en)
|
2006-04-11 |
2014-09-23 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of voltage-gated sodium channels
|
|
AU2007257959A1
(en)
|
2006-06-09 |
2007-12-21 |
Kemia, Inc. |
Therapy using cytokine inhibitors
|
|
WO2008001195A2
(en)
|
2006-06-27 |
2008-01-03 |
Glenmark Pharmaceuticals S.A. |
Novel processes for the preparation of dpp iv inhibitors
|
|
US7842672B2
(en)
|
2006-07-07 |
2010-11-30 |
Gilead Sciences, Inc. |
Phosphonate inhibitors of HCV
|
|
PE20080948A1
(es)
|
2006-07-25 |
2008-09-10 |
Irm Llc |
Derivados de imidazol como moduladores de la senda de hedgehog
|
|
EP1882475A1
(en)
|
2006-07-26 |
2008-01-30 |
Novartis AG |
Method of treating disorders mediated by the fibroblast growth factor receptor
|
|
KR20150036358A
(ko)
|
2006-08-08 |
2015-04-07 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
E1 활성화 효소의 억제제로서 유용한 헤테로아릴 화합물
|
|
JP5244596B2
(ja)
|
2006-08-09 |
2013-07-24 |
株式会社アイエスティー |
タンパク質の検出方法及びそれに用いる蛍光色素
|
|
WO2008033743A1
(en)
|
2006-09-11 |
2008-03-20 |
Curis, Inc. |
Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety
|
|
EP2061468A4
(en)
|
2006-09-11 |
2011-05-04 |
Curis Inc |
TYROSINE KINASE INHIBITORS CONTAINING ZINC BINDING CHARACTERISTIC GROUP
|
|
RU2009117642A
(ru)
|
2006-10-12 |
2010-11-20 |
Ксенон Фармасьютикалз Инк. (Ca) |
Применение спирооксиндоловых соединений в качестве терапевтических средств
|
|
JP2010510974A
(ja)
|
2006-11-27 |
2010-04-08 |
ノバルティス アーゲー |
置換ジヒドロイミダゾールおよび腫瘍の処置におけるその使用
|
|
EP2101760B1
(en)
|
2006-12-08 |
2013-02-27 |
Millennium Pharmaceuticals, Inc. |
Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor
|
|
US8236950B2
(en)
|
2006-12-20 |
2012-08-07 |
Abbott Laboratories |
Anti-viral compounds
|
|
FR2911138B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
FR2911140B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de 2-anilino 4-heteroaryle pyrimides, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
FR2911139A1
(fr)
|
2007-01-05 |
2008-07-11 |
Sanofi Aventis Sa |
Nouveaux derives de phenyl-(4-phenyl-pyrimidin-2-yl)amines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
WO2008094507A2
(en)
|
2007-01-26 |
2008-08-07 |
Cellicon Biotechnologies, Inc. |
Novel fusion compounds
|
|
CA2680398A1
(en)
|
2007-03-20 |
2008-09-25 |
Curis, Inc. |
Raf kinase inhibitors containing a zinc binding moiety
|
|
WO2008115262A2
(en)
|
2007-03-20 |
2008-09-25 |
Curis, Inc. |
Hsp90 inhibitors containing a zinc binding moiety
|
|
GEP20125379B
(en)
|
2007-05-03 |
2012-01-10 |
Pfizer Ltd |
2 -pyridine carboxamide derivatives as sodium channel modulators
|
|
EP2167058B1
(en)
|
2007-06-18 |
2015-08-12 |
University Of Louisville Research Foundation, Inc. |
Family of pfkfb3 inhibitors with anti-neoplastic activities
|
|
WO2009000413A1
(en)
|
2007-06-26 |
2008-12-31 |
Sanofi-Aventis |
A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
|
|
SI2178865T1
(sl)
|
2007-07-19 |
2015-11-30 |
Lundbeck, H., A/S |
5-členski heterociklični amidi in sorodne spojine
|
|
JP4834699B2
(ja)
|
2007-07-30 |
2011-12-14 |
田辺三菱製薬株式会社 |
医薬組成物
|
|
JP4846769B2
(ja)
|
2007-07-30 |
2011-12-28 |
田辺三菱製薬株式会社 |
医薬組成物
|
|
FR2919869B1
(fr)
|
2007-08-09 |
2009-09-25 |
Sanofi Aventis Sa |
Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
WO2009036066A1
(en)
|
2007-09-10 |
2009-03-19 |
Curis, Inc. |
Vegfr inhibitors containing a zinc binding moiety
|
|
TW200920357A
(en)
|
2007-09-10 |
2009-05-16 |
Curis Inc |
HSP90 inhibitors containing a zinc binding moiety
|
|
WO2009036051A1
(en)
|
2007-09-10 |
2009-03-19 |
Curis, Inc. |
Bcl-2 inhibitors containing a zinc binding moiety
|
|
TW200930703A
(en)
|
2007-09-26 |
2009-07-16 |
Astellas Pharma Inc |
Quinolone derivative
|
|
EP2195304B1
(en)
|
2007-10-08 |
2014-01-08 |
Advinus Therapeutics Private Limited |
Acetamide derivatives as glucokinase activators, their process and medicinal applications
|
|
EP2212292B1
(en)
|
2007-10-11 |
2012-12-05 |
Vertex Pharmaceuticals Incorporated |
Amides useful as inhibitors of voltage-gated sodium channels
|
|
MX2010003865A
(es)
|
2007-10-11 |
2010-06-01 |
Vertex Pharma |
Aril amidas utiles como inhibidores de canales de sodio dependientes de voltaje.
|
|
US8519137B2
(en)
|
2007-10-11 |
2013-08-27 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
|
|
WO2009069132A2
(en)
|
2007-11-29 |
2009-06-04 |
Ramot At Tel Aviv University Ltd. |
Novel reverse transcriptase inhibitors
|
|
AU2008335031B2
(en)
|
2007-12-13 |
2013-11-28 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
US8642660B2
(en)
|
2007-12-21 |
2014-02-04 |
The University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
WO2009091941A1
(en)
|
2008-01-17 |
2009-07-23 |
Purdue Research Foundation |
Small molecule inhibitors of hiv proteases
|
|
US20120108630A1
(en)
|
2008-02-12 |
2012-05-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hedgehog Pathway Antagonists and Methods of Use
|
|
WO2009114470A2
(en)
|
2008-03-10 |
2009-09-17 |
Curis, Inc. |
Tetrahydroindole and tetrahdyroindazole as hsp90 inhibitors containing a zinc binding moiety
|
|
JP5219583B2
(ja)
|
2008-03-31 |
2013-06-26 |
住友化学株式会社 |
組成物、光学フィルムとその製造方法、光学部材及び表示装置
|
|
PE20091838A1
(es)
|
2008-04-09 |
2009-12-18 |
Infinity Pharmaceuticals Inc |
Inhibidores de amida hidrolasa de acido graso
|
|
JP5507552B2
(ja)
|
2008-06-16 |
2014-05-28 |
ユニバーシティ オブ テネシー リサーチ ファウンデーション |
癌を処置するための化合物
|
|
US9029408B2
(en)
|
2008-06-16 |
2015-05-12 |
Gtx, Inc. |
Compounds for treatment of cancer
|
|
CN104193740A
(zh)
|
2008-07-03 |
2014-12-10 |
西特里斯药业公司 |
作为沉默调节蛋白调节剂的苯并咪唑类和相关的类似物
|
|
JP5443720B2
(ja)
|
2008-09-05 |
2014-03-19 |
住友化学株式会社 |
組成物、光学フィルム及びその製造方法、光学部材ならびに表示装置
|
|
US8541569B2
(en)
|
2008-09-06 |
2013-09-24 |
Chemgenes Corporation |
Phosphoramidites for synthetic RNA in the reverse direction, efficient RNA synthesis and convenient introduction of 3'-end ligands, chromophores and modifications of synthetic RNA
|
|
CN102439025B
(zh)
|
2008-09-06 |
2017-08-01 |
坎姆根公司 |
Rna合成-用于反向合成rna的亚磷酰胺,以及在3’‑末端合成rna的配体、发色团和修饰物的方便引入中的应用
|
|
RU2506257C2
(ru)
|
2008-09-18 |
2014-02-10 |
Ф.Хоффманн-Ля Рош Аг |
Замещенные пирролидин-2-карбоксамиды
|
|
US8354444B2
(en)
|
2008-09-18 |
2013-01-15 |
Hoffmann-La Roche Inc. |
Substituted pyrrolidine-2-carboxamides
|
|
ES2517690T3
(es)
|
2008-09-29 |
2014-11-03 |
Glaxosmithkline Llc |
Quinazolinona, quinolona y análogos relacionados como moduladores de sirtuina
|
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
|
EP2184273A1
(de)
|
2008-11-05 |
2010-05-12 |
Bayer CropScience AG |
Halogen-substituierte Verbindungen als Pestizide
|
|
US20120165304A1
(en)
|
2008-11-27 |
2012-06-28 |
Boehringer Ingelheim International Gmbh |
6,7,8,9-Tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
|
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
|
US20110237622A1
(en)
|
2008-12-10 |
2011-09-29 |
Merck Frosst Canada Ltd. |
Renin inhibitors
|
|
US20120040916A1
(en)
|
2008-12-22 |
2012-02-16 |
Massachusetts Institute Of Technology |
Molecular inhibitors of the wnt/beta-catenin pathway
|
|
CN102264722B
(zh)
|
2008-12-23 |
2014-04-02 |
霍夫曼-拉罗奇有限公司 |
作为p2x7调节剂的二氢吡啶酮酰胺
|
|
ES2620446T3
(es)
|
2008-12-26 |
2017-06-28 |
Sumitomo Dainippon Pharma Co., Ltd. |
Nuevo compuesto heterocíclico bicíclico
|
|
KR20100087540A
(ko)
|
2009-01-28 |
2010-08-05 |
삼성전자주식회사 |
잉크젯 기록용 잉크 조성물
|
|
EP2408449A4
(en)
|
2009-03-18 |
2012-08-08 |
Univ Leland Stanford Junior |
METHOD AND COMPOSITIONS FOR TREATING FLAVIVIRIDAE VIRUS INFECTIONS
|
|
WO2010115736A2
(en)
|
2009-04-02 |
2010-10-14 |
Merck Serono S.A. |
Dihydroorotate dehydrogenase inhibitors
|
|
TWI638807B
(zh)
|
2009-04-28 |
2018-10-21 |
環球展覽公司 |
具有甲基-d3取代之銥錯合物
|
|
JP6186125B2
(ja)
|
2009-05-07 |
2017-08-30 |
ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ |
疼痛の研究、画像化および治療方法、ならびに疼痛の研究、画像化および治療のための組成物
|
|
JP2012528174A
(ja)
|
2009-05-27 |
2012-11-12 |
アボット・ラボラトリーズ |
キナーゼ活性のピリミジン阻害剤
|
|
MX2011012631A
(es)
|
2009-05-27 |
2012-03-06 |
Abbott Lab |
Inhibidores de actividad de cinasa tipo pirimidina.
|
|
US9101616B2
(en)
|
2009-05-29 |
2015-08-11 |
Raqualia Pharma Inc. |
Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
|
|
TW201103904A
(en)
|
2009-06-11 |
2011-02-01 |
Hoffmann La Roche |
Janus kinase inhibitor compounds and methods
|
|
AR077252A1
(es)
|
2009-06-29 |
2011-08-10 |
Xenon Pharmaceuticals Inc |
Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
|
|
WO2011005860A2
(en)
|
2009-07-07 |
2011-01-13 |
Alnylam Pharmaceuticals, Inc. |
5' phosphate mimics
|
|
CA2771472A1
(en)
|
2009-09-04 |
2011-03-10 |
Zalicus Pharmaceuticals Ltd. |
Oxopiperazine derivatives for the treatment of pain and epilepsy
|
|
CA2773561A1
(en)
|
2009-09-14 |
2011-03-17 |
Phusis Therapeutics Inc. |
Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
|
|
US20110124597A1
(en)
|
2009-09-25 |
2011-05-26 |
Anacor Pharmaceuticals, Inc. |
Boron containing small molecules
|
|
EP3421476A1
(en)
|
2009-10-16 |
2019-01-02 |
Melinta Therapeutics, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
US11084811B2
(en)
|
2010-03-01 |
2021-08-10 |
Oncternal Therapeutics, Inc. |
Compounds for treatment of cancer
|
|
JP5879273B2
(ja)
|
2010-03-01 |
2016-03-08 |
ジーティーエックス・インコーポレイテッド |
癌を処置するための化合物
|
|
HUE028983T2
(en)
|
2010-05-06 |
2017-01-30 |
Vertex Pharma |
Heterocyclic chromene-spirocyclic piperidine amides as ion channel modulators
|
|
US20130116284A1
(en)
|
2010-05-10 |
2013-05-09 |
Radikal Therapeutics Inc. |
Lipoic acid and nitroxide derivatives and uses thereof
|
|
WO2011151619A1
(en)
|
2010-06-01 |
2011-12-08 |
Summit Corporation Plc |
Compounds for the treatment of clostridium difficile associated disease
|
|
US20120010235A1
(en)
|
2010-07-12 |
2012-01-12 |
Xin-Jie Chu |
N-substituted pyrrolidines
|
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
|
US9290485B2
(en)
|
2010-08-04 |
2016-03-22 |
Novartis Ag |
N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides
|
|
WO2012020725A1
(ja)
|
2010-08-10 |
2012-02-16 |
塩野義製薬株式会社 |
Npy y5受容体拮抗作用を有するヘテロ環誘導体
|
|
BR112013008240A2
(pt)
|
2010-10-08 |
2017-12-12 |
Abbvie Inc |
compostos de furo [3-2-d] pirimidina
|
|
GB201017315D0
(en)
|
2010-10-13 |
2010-11-24 |
Antoxis Ltd |
Compound
|
|
EP2630136A1
(en)
|
2010-10-21 |
2013-08-28 |
Universität des Saarlandes |
Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases
|
|
FI20106119A0
(fi)
|
2010-10-27 |
2010-10-27 |
Sirtuin Valley Oy |
Energia-aineenvaihduntaan vaikuttava koostumus
|
|
GB201020076D0
(en)
|
2010-11-26 |
2011-01-12 |
Liverpool School Tropical Medicine |
Antimalarial compounds
|
|
DK2646436T3
(en)
|
2010-11-29 |
2015-06-29 |
Pfizer |
monobactams
|
|
CA2818903C
(en)
|
2010-12-14 |
2021-03-23 |
Electrophoretics Limited |
5-(1,3-benzoxazol-2-yl)-4-(pyridin-4-yl)pyrimidin-2-amine and its use as a casein kinase 1delta inhibitor
|
|
TWI574687B
(zh)
|
2011-01-03 |
2017-03-21 |
古利斯股份有限公司 |
具有鋅結合部份之刺蝟拮抗劑
|
|
WO2012097330A2
(en)
|
2011-01-14 |
2012-07-19 |
University Of Washington |
Compositions and methods for treating degenerative muscle conditions
|
|
WO2012106534A2
(en)
|
2011-02-02 |
2012-08-09 |
The Regents Of The University Of California |
Hiv integrase inhibitors
|
|
US9592540B2
(en)
|
2011-02-02 |
2017-03-14 |
Bio-Rad Laboratories, Inc. |
Apatite surface neutralization with alkali solutions
|
|
RU2634900C2
(ru)
|
2011-02-02 |
2017-11-08 |
Вертекс Фармасьютикалз Инкорпорейтед |
Спироциклические пирролопиразин(пиперидин)амиды в качестве модуляторов ионных каналов
|
|
JP2012167027A
(ja)
|
2011-02-10 |
2012-09-06 |
Shionogi & Co Ltd |
Npyy5受容体拮抗作用を有する縮合ヘテロ環誘導体
|
|
US10385070B2
(en)
|
2011-02-18 |
2019-08-20 |
Vertex Pharmaceuticals Incorporated |
Chroman-spirocyclic piperidine amides as modulators of ion channels
|
|
EP2681200A4
(en)
|
2011-03-03 |
2015-05-27 |
Zalicus Pharmaceuticals Ltd |
INHIBITORS OF BENZIMIDAZOLE TYPE OF SODIUM CHANNEL
|
|
AU2012229187B2
(en)
|
2011-03-14 |
2016-11-10 |
Vertex Pharmaceuticals Incorporated |
Morpholine-spirocyclic piperidine amides as modulators of ion channels
|
|
TW201247610A
(en)
|
2011-03-15 |
2012-12-01 |
Abbott Lab |
Nuclear hormone receptor modulators
|
|
US9464065B2
(en)
|
2011-03-24 |
2016-10-11 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
|
JP5866100B2
(ja)
|
2011-04-13 |
2016-02-17 |
住友化学株式会社 |
レジスト組成物及びレジストパターンの製造方法
|
|
CN103717605B
(zh)
|
2011-05-11 |
2016-05-18 |
密执安州立大学董事会 |
螺-羟吲哚mdm2拮抗剂
|
|
JP6007417B2
(ja)
|
2011-05-31 |
2016-10-12 |
レセプトス エルエルシー |
新規glp−1受容体安定剤および調節剤
|
|
WO2012170371A1
(en)
|
2011-06-10 |
2012-12-13 |
N30 Pharmaceuticals, Llc |
Compounds as s-nitrosoglutathione reductase inhibitors
|
|
JP2014520161A
(ja)
|
2011-06-22 |
2014-08-21 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Atrキナーゼ阻害剤として有用な化合物
|
|
WO2013005057A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
New compounds
|
|
GB201111705D0
(en)
|
2011-07-07 |
2011-08-24 |
Takeda Pharmaceutical |
Compounds and their use
|
|
WO2013022740A2
(en)
|
2011-08-05 |
2013-02-14 |
Corning Incorporated |
Gpr35 ligands and the uses thereof
|
|
EP2755965B1
(en)
|
2011-09-12 |
2017-07-26 |
Merck Patent GmbH |
Novel imidazole amines as modulators of kinase activity
|
|
WO2013049725A2
(en)
|
2011-09-30 |
2013-04-04 |
Tufts University |
Methods of using adenosine a1 receptor activation for treating depression
|
|
MD20140037A2
(ro)
|
2011-10-26 |
2014-08-31 |
Pfizer Limited |
Derivaţi de (4-fenilimidazol-2-il)etilamină utili ca modulatori ai canalului de sodiu
|
|
WO2013086229A1
(en)
|
2011-12-07 |
2013-06-13 |
Amgen Inc. |
Bicyclic aryl and heteroaryl sodium channel inhibitors
|
|
CN103159738B
(zh)
|
2011-12-19 |
2016-09-07 |
上海泓博智源医药股份有限公司 |
炔基桥连的杂芳香化合物及其应用
|
|
MX2014008591A
(es)
|
2012-01-16 |
2014-08-22 |
Vertex Pharma |
Piperidinamidas piranoespirociclicas como moduladores de canales de iones.
|
|
FR2985916B1
(fr)
|
2012-01-25 |
2015-12-04 |
Univ Bordeaux Segalen |
Decontamination par hydrogels d'echantillons aqueux contenant des nanoparticules
|
|
JP6002785B2
(ja)
|
2012-02-03 |
2016-10-05 |
ファイザー・インク |
ナトリウムチャネルモジュレーターとしてのベンゾイミダゾールおよびイミダゾピリジン誘導体
|
|
CA2864091A1
(en)
|
2012-02-08 |
2013-08-15 |
Graffinity Pharmaceuticals Gmbh |
Ligands for antibody and fc-fusion protein purification by affinity chromatography iv
|
|
WO2013124040A1
(en)
|
2012-02-22 |
2013-08-29 |
Merck Patent Gmbh |
Liquid crystalline medium
|
|
WO2013131018A1
(en)
|
2012-03-02 |
2013-09-06 |
Zalicus Pharmaceuticals Ltd. |
Biaryl inhibitors of the sodium channel
|
|
BR112014022106B1
(pt)
|
2012-03-06 |
2022-08-02 |
Pfizer Inc |
Derivados macrocíclicos, combinação, composição e usos na fabricação de um medicamento para o tratamento de doenças
|
|
JP5798066B2
(ja)
|
2012-03-08 |
2015-10-21 |
富士フイルム株式会社 |
化合物、液晶組成物、高分子材料およびフィルム
|
|
WO2013134518A1
(en)
|
2012-03-09 |
2013-09-12 |
Amgen Inc. |
Sulfamide sodium channel inhibitors
|
|
JP5804991B2
(ja)
|
2012-03-19 |
2015-11-04 |
富士フイルム株式会社 |
光反射フィルム、自動車用フロントガラス、建材用ガラス
|
|
WO2013151975A1
(en)
|
2012-04-02 |
2013-10-10 |
Northeastern University |
Compositions and methods for the inhibition of methyltransferases
|
|
KR101714856B1
(ko)
|
2012-05-30 |
2017-03-09 |
에프. 호프만-라 로슈 아게 |
치환된 피롤리딘-2-카복스아미드
|
|
JP5867298B2
(ja)
|
2012-06-06 |
2016-02-24 |
Jsr株式会社 |
フォトレジスト組成物及びレジストパターン形成方法
|
|
WO2013188881A1
(en)
|
2012-06-15 |
2013-12-19 |
President And Fellows Of Harvard College |
Compounds, compositions and methods for treating or preventing neurodegenerative disorders
|
|
US20140005181A1
(en)
|
2012-06-21 |
2014-01-02 |
Sanford-Burnham Medical Research Institute |
Small molecule antagonists of the apelin receptor for the treatment of disease
|
|
WO2014003153A1
(ja)
|
2012-06-28 |
2014-01-03 |
協和発酵キリン株式会社 |
置換アミド化合物
|
|
US9682970B2
(en)
|
2012-06-29 |
2017-06-20 |
Biotium, Inc. |
Fluorescent compounds and uses thereof
|
|
US9040498B2
(en)
|
2012-07-06 |
2015-05-26 |
Research Foundation Of The City University Of New York |
1,2,3-Triazolyl purine derivatives
|
|
WO2014014874A1
(en)
|
2012-07-17 |
2014-01-23 |
Boehringer Ingelheim International Gmbh |
Pyrazole derivatives which inhibit leukotriene production
|
|
JP6220786B2
(ja)
|
2012-07-19 |
2017-10-25 |
大日本住友製薬株式会社 |
1−(シクロアルキルカルボニル)プロリン誘導体
|
|
WO2014015523A1
(en)
|
2012-07-27 |
2014-01-30 |
Hutchison Medipharma Limited |
Novel heteroaryl and heterocycle compounds, compositions and methods
|
|
KR102127025B1
(ko)
|
2012-07-27 |
2020-06-25 |
비오겐 엠에이 아이엔씨. |
S1p 조절제 및/또는 atx 조절제인 화합물들
|
|
WO2014020152A1
(en)
|
2012-08-02 |
2014-02-06 |
Graffinity Pharmaceuticals Gmbh |
Ligands for apheresis and immunoabsorption
|
|
US9428511B2
(en)
|
2012-09-06 |
2016-08-30 |
Bristol-Myers Squibb Company |
Imidazopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
|
|
CN104812382A
(zh)
|
2012-09-20 |
2015-07-29 |
坦普尔大学 |
取代的烷基二芳基衍生物、制备方法和用途
|
|
UA110688C2
(uk)
|
2012-09-21 |
2016-01-25 |
Пфайзер Інк. |
Біциклічні піридинони
|
|
FR2997851B1
(fr)
|
2012-11-09 |
2014-11-28 |
Oreal |
Composition comprenant un derive dicarbonyle et procede de lissage des cheveux a partir de cette composition
|
|
WO2014078479A2
(en)
|
2012-11-14 |
2014-05-22 |
The Board Of Regents Of The University Of Texas System |
INHIBITION OF HIF-2α HETERODIMERIZATION WITH HIF1β (ARNT)
|
|
RU2661896C2
(ru)
|
2012-11-16 |
2018-07-23 |
Мерк Шарп И Доум Корп. |
Пуриновые ингибиторы фосфатидилинозитол-3-киназы дельта человека
|
|
US9884886B2
(en)
|
2012-12-06 |
2018-02-06 |
Merck Sharp & Dohme |
Disulfide masked prodrug compositions and methods
|
|
RU2015125570A
(ru)
|
2013-01-08 |
2017-02-10 |
Савира Фармасьютикалз Гмбх |
Пиридоновые производные и их применение в лечении, уменьшении интенсивности симптомов или предотвращении вирусного заболевания
|
|
US20140200215A1
(en)
|
2013-01-15 |
2014-07-17 |
Intermune, Inc. |
Lysophosphatidic acid receptor antagonists
|
|
CN105026387B
(zh)
|
2013-01-29 |
2018-06-08 |
Redx制药公开有限公司 |
作为软rock抑制剂的吡啶衍生物
|
|
TWI606048B
(zh)
|
2013-01-31 |
2017-11-21 |
帝人製藥股份有限公司 |
唑苯衍生物
|
|
TWI659945B
(zh)
|
2013-01-31 |
2019-05-21 |
維泰克斯製藥公司 |
作爲鈉通道調節劑之醯胺
|
|
NZ710270A
(en)
|
2013-01-31 |
2020-09-25 |
Vertex Pharma |
Pyridone amides as modulators of sodium channels
|
|
KR102226587B1
(ko)
|
2013-01-31 |
2021-03-11 |
버텍스 파마슈티칼스 인코포레이티드 |
나트륨 채널의 조절제로서의 퀴놀린 및 퀴나졸린 아미드
|
|
WO2014130856A2
(en)
|
2013-02-21 |
2014-08-28 |
Wayne Rothbaum |
Treatment of skeletal-related disorders
|
|
US9580400B2
(en)
|
2013-02-26 |
2017-02-28 |
Northeastern University |
Cannabinergic nitrate esters and related analogs
|
|
WO2014151958A1
(en)
|
2013-03-14 |
2014-09-25 |
VenatoRx Pharmaceuticals, Inc. |
Beta-lactamase inhibitors
|
|
US9357781B2
(en)
|
2013-05-03 |
2016-06-07 |
Inscent, Inc. |
Honeybee repellents and uses thereof
|
|
JP2014232188A
(ja)
|
2013-05-29 |
2014-12-11 |
コニカミノルタ株式会社 |
セルロースアシレートフィルム、円偏光板及び画像表示装置
|
|
US9212182B2
(en)
|
2013-06-12 |
2015-12-15 |
Amgen Inc. |
Bicyclic sulfonamide compounds as sodium channel inhibitors
|
|
TWI637949B
(zh)
|
2013-06-14 |
2018-10-11 |
塩野義製藥股份有限公司 |
胺基三衍生物及含有其等之醫藥組合物
|
|
TW201534597A
(zh)
|
2013-06-20 |
2015-09-16 |
Ab Science |
作為選擇性蛋白質激酶抑制劑之苯并咪唑衍生物
|
|
WO2015003991A1
(en)
|
2013-07-12 |
2015-01-15 |
Syngenta Participations Ag |
Novel microbiocides
|
|
WO2015003723A1
(en)
|
2013-07-12 |
2015-01-15 |
Københavns Universitet |
Substituted 4-proline derivatives as iglur antagonists
|
|
CA2917767C
(en)
|
2013-07-12 |
2022-05-03 |
Helmholtz-Zentrum Fur Infektionsforschung Gmbh |
Cystobactamides
|
|
MX364155B
(es)
|
2013-07-19 |
2019-04-12 |
Vertex Pharma |
Sulfonamidas como moduladores de canales de sodio.
|
|
AU2014295000A1
(en)
|
2013-07-25 |
2016-02-18 |
Fondazione Telethon |
Inhibitors of FAPP2 and uses thereof
|
|
EP3041470A4
(en)
|
2013-09-04 |
2017-05-03 |
Board Of Regents Of the University Of Texas System |
Methods and compositions for selective and targeted cancer therapy
|
|
LT3043803T
(lt)
|
2013-09-11 |
2022-08-10 |
Emory University |
Nukleotidų ir nukleozidų kompozicijos ir jų panaudojimas
|
|
KR101628288B1
(ko)
|
2013-09-30 |
2016-06-08 |
주식회사 엘지화학 |
음성 광학 분산도를 갖는 광학 소자 제조용 조성물 및 이로부터 제조된 광학 이방체
|
|
KR20160060660A
(ko)
|
2013-10-01 |
2016-05-30 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
친화성 크로마토그래피를 위한 및 치료제의 반감기를 연장시키기 위한 화합물
|
|
EP3052479A4
(en)
|
2013-10-02 |
2017-10-25 |
Moderna Therapeutics, Inc. |
Polynucleotide molecules and uses thereof
|
|
WO2015054337A1
(en)
|
2013-10-09 |
2015-04-16 |
Emory University |
Heterocyclic coupling catalysts and methods related thereto
|
|
KR102395827B1
(ko)
|
2013-12-03 |
2022-05-10 |
에프엠씨 코포레이션 |
제초제로서의 피롤리디논
|
|
WO2015085238A1
(en)
|
2013-12-05 |
2015-06-11 |
The Regents Of The University Of California, A California Corporation |
Inhibitors of lpxc
|
|
EP2918275B1
(en)
|
2013-12-13 |
2016-05-18 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
|
DK3080134T3
(en)
|
2013-12-13 |
2018-10-22 |
Vertex Pharma |
PRODRUGS OF PYRIDONAMIDS USED AS MODULATORS OF SODIUM CHANNELS
|
|
US10131841B2
(en)
|
2013-12-16 |
2018-11-20 |
Merck Patent Gmbh |
Liquid-crystalline medium
|
|
BR112016015449A8
(pt)
|
2013-12-30 |
2020-06-09 |
Lifesci Pharmaceuticals Inc |
compostos inibidores terapêuticos, composição farmacêutica os compreendendo e uso dos mesmos
|
|
US9611252B2
(en)
|
2013-12-30 |
2017-04-04 |
Lifesci Pharmaceuticals, Inc. |
Therapeutic inhibitory compounds
|
|
AU2015243437B2
(en)
|
2014-04-09 |
2019-08-29 |
Siteone Therapeutics, Inc. |
10',11'-modified saxitoxins useful for the treatment of pain
|
|
WO2015162244A1
(en)
|
2014-04-25 |
2015-10-29 |
Basf Se |
N-acylamidine compounds
|
|
JP6295992B2
(ja)
|
2014-05-09 |
2018-03-20 |
信越化学工業株式会社 |
単量体の製造方法
|
|
US9701627B2
(en)
|
2014-06-16 |
2017-07-11 |
University Of Maryland, Baltimore |
LRRK2 GTP binding inhibitors for treatment of Parkinson's disease and neuroinflammatory disorders
|
|
US20170136132A1
(en)
|
2014-06-19 |
2017-05-18 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
|
EP3157573A4
(en)
|
2014-06-19 |
2018-02-21 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
|
US20170175129A1
(en)
|
2014-06-19 |
2017-06-22 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
|
CA2952968A1
(en)
|
2014-07-01 |
2016-01-07 |
Rempex Pharmaceuticals, Inc. |
Boronic acid derivatives and therapeutic uses thereof
|
|
WO2016007837A1
(en)
|
2014-07-11 |
2016-01-14 |
Spero Therapeutics, Inc. |
Carbonyl linked bicyclic heteroaryl antibiotic tolerance inhibitors
|
|
CN107072985B
(zh)
|
2014-07-16 |
2020-02-07 |
莱福斯希医药公司 |
治疗性抑制化合物
|
|
EP2977374A1
(en)
|
2014-07-21 |
2016-01-27 |
Université de Strasbourg |
Molecules presenting dual emission properties
|
|
EP2985334B1
(en)
|
2014-08-15 |
2018-06-20 |
Merck Patent GmbH |
Liquid-crystalline medium
|
|
WO2016029146A1
(en)
|
2014-08-22 |
2016-02-25 |
University Of Washington |
Specific inhibitors of methionyl-trna synthetase
|
|
CA2960275A1
(en)
|
2014-09-10 |
2016-03-17 |
Epizyme, Inc. |
Smyd inhibitors
|
|
WO2016040449A1
(en)
|
2014-09-10 |
2016-03-17 |
Raze Therapeutics, Inc. |
3-phosphoglycerate dehydrogenase inhibitors and uses thereof
|
|
JP2016079098A
(ja)
|
2014-10-10 |
2016-05-16 |
塩野義製薬株式会社 |
セフェム化合物
|
|
JP2017538676A
(ja)
|
2014-11-05 |
2017-12-28 |
ザ ユニバーシティ オブ カンザス |
ミトコンドリア透過性遷移孔(mtPTP)の小分子阻害剤
|
|
WO2016094702A2
(en)
|
2014-12-10 |
2016-06-16 |
Mars, Incorporated |
Methods for modulating taste receptors
|
|
FR3030242B1
(fr)
|
2014-12-18 |
2018-01-26 |
L'oreal |
Emulsion contenant un tensioactif gemine ayant deux groupements amide gras et un filtre uv organique hydrosoluble
|
|
CN105985330A
(zh)
|
2015-02-04 |
2016-10-05 |
苏州旺山旺水生物医药有限公司 |
一类杂环化合物、其制备方法和用途
|
|
JP6394430B2
(ja)
|
2015-02-13 |
2018-09-26 |
信越化学工業株式会社 |
化合物、高分子化合物、レジスト材料及びパターン形成方法
|
|
CR20170392A
(es)
|
2015-03-02 |
2018-02-20 |
Amgen Inc |
Compuestos bicíclicos de sulfonamida cetona
|
|
WO2016145142A1
(en)
|
2015-03-10 |
2016-09-15 |
Emory University |
Nucleotide and nucleoside therapeutics compositions and uses related thereto
|
|
EP3085360A1
(en)
|
2015-04-20 |
2016-10-26 |
Universite De Bordeaux |
Lipid based nanocarrier compositions loaded with metal nanoparticles and therapeutic agent
|
|
WO2016172631A2
(en)
|
2015-04-24 |
2016-10-27 |
President And Fellows Of Harvard College |
Substrate selective inhibitors of insulin-degrading enzyme (ide) and uses thereof
|
|
CN107849024A
(zh)
|
2015-05-15 |
2018-03-27 |
吉利德科学公司 |
具有作为吲哚胺2,3‑二加氧酶抑制剂活性的苯并咪唑和咪唑并吡啶亚氨代甲酰胺化合物
|
|
CN107709310B
(zh)
|
2015-06-02 |
2021-09-24 |
Fmc公司 |
取代的环酰胺及其作为除草剂的用途
|
|
WO2016198908A1
(en)
|
2015-06-09 |
2016-12-15 |
Abbvie Inc. |
Ror nuclear receptor modulators
|
|
CA2991261A1
(en)
|
2015-07-06 |
2017-01-12 |
Bayer Cropscience Aktiengesellschaft |
Nitrogenous heterocycles as a pesticide
|
|
CN108137507A
(zh)
|
2015-07-10 |
2018-06-08 |
阿尔维纳斯股份有限公司 |
基于mdm2的蛋白水解调节剂和相关的使用方法
|
|
CN106518767A
(zh)
|
2015-09-11 |
2017-03-22 |
中国人民解放军军事医学科学院毒物药物研究所 |
取代苯并吡唑二芳基脲类化合物,其制备方法及其医药用途
|
|
CN106518766A
(zh)
|
2015-09-11 |
2017-03-22 |
中国人民解放军军事医学科学院毒物药物研究所 |
新型二芳基脲类化合物,其制备方法及其医药用途
|
|
WO2017051319A1
(en)
|
2015-09-21 |
2017-03-30 |
Glenmark Pharmaceuticals S.A. |
Aryl and heteroaryl ether compounds as ror gamma modulators
|
|
US10112953B2
(en)
|
2015-09-30 |
2018-10-30 |
Siteone Therapeutics, Inc. |
11,13-modified saxitoxins for the treatment of pain
|
|
WO2017059446A1
(en)
|
2015-10-01 |
2017-04-06 |
Memorial Sloan-Kettering Cancer Center |
Anthranilyl-adenosinemonosulfamate analogs and uses thereof
|
|
US11413278B2
(en)
|
2015-10-08 |
2022-08-16 |
The Regents Of The University Of California |
Compounds and methods for promoting stress resistance
|
|
US20180305334A1
(en)
|
2015-10-14 |
2018-10-25 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use against stress granules
|
|
WO2017066782A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Hydrophobic mrna cap analogs
|
|
EP3362461B1
(en)
|
2015-10-16 |
2022-03-16 |
Modernatx, Inc. |
Mrna cap analogs with modified phosphate linkage
|
|
WO2017066791A1
(en)
|
2015-10-16 |
2017-04-20 |
Modernatx, Inc. |
Sugar substituted mrna cap analogs
|
|
JP6837004B2
(ja)
|
2015-11-27 |
2021-03-03 |
田辺三菱製薬株式会社 |
新規イミダゾール化合物およびメラノコルチン受容体作動薬としての用途
|
|
GB201522232D0
(en)
|
2015-12-16 |
2016-01-27 |
Liverpool School Tropical Medicine |
Combination product
|
|
KR102606339B1
(ko)
|
2016-03-02 |
2023-11-24 |
삼성전자주식회사 |
유기금속 화합물 및 이를 포함한 유기 발광 소자
|
|
SMT202300273T1
(it)
|
2016-03-16 |
2023-09-06 |
Kura Oncology Inc |
Derivati di tieno[2,3–d]pirimidina sostituiti come inibitori di menina–mll e metodi d’uso
|
|
GB201604638D0
(en)
|
2016-03-18 |
2016-05-04 |
Mission Therapeutics Ltd |
Novel compounds
|
|
US10738030B2
(en)
|
2016-03-31 |
2020-08-11 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
|
CN105906591A
(zh)
|
2016-04-22 |
2016-08-31 |
中国药科大学 |
2-氨基-γ-丁内酯类盐酸盐的合成
|
|
WO2017223260A1
(en)
|
2016-06-23 |
2017-12-28 |
Albert Einstein College Of Medicine, Inc. |
Pu.1 inhibitors
|
|
CN106220667B
(zh)
|
2016-07-21 |
2018-10-30 |
北京航空航天大学 |
螺环有机硅化合物及其应用
|
|
WO2018045106A1
(en)
|
2016-08-30 |
2018-03-08 |
Ohio State Innovation Foundation |
Anti-fungal treatment
|
|
WO2018055235A1
(en)
|
2016-09-21 |
2018-03-29 |
University Of Helsinki |
Isoxazole-amides for treating cardiac diseases
|
|
CA3038331A1
(en)
|
2016-09-28 |
2018-04-05 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
WO2018060110A1
(en)
|
2016-09-28 |
2018-04-05 |
Merck Patent Gmbh |
Polymerisable liquid crystal material and polymerised liquid crystal film
|
|
US11179708B2
(en)
|
2016-10-04 |
2021-11-23 |
Massachusetts Institute Of Technology |
Compositions and methods for selective carbonylation of heterocyclic compounds
|
|
US11142535B2
(en)
|
2016-12-12 |
2021-10-12 |
Hangzhou Innogate Pharma Co., Ltd. |
Heterocyclic compound as Syk inhibitor and/or Syk-HDAC dual inhibitor
|
|
WO2018138358A1
(en)
|
2017-01-30 |
2018-08-02 |
Université de Liège |
Perk and ire-1a inhibitors against neurodevelopmental disorders
|
|
WO2018161033A1
(en)
|
2017-03-02 |
2018-09-07 |
Wright, Adrian |
Small molecule ire1-alpha inhibitors
|
|
CN108658974A
(zh)
|
2017-03-28 |
2018-10-16 |
中国海洋大学 |
一种内酰胺类化合物及其制备方法和用途
|
|
CN108658972A
(zh)
|
2017-03-28 |
2018-10-16 |
中国海洋大学 |
一种取代内酰胺类化合物及其制备方法和用途
|
|
JP7090100B2
(ja)
|
2017-03-29 |
2022-06-23 |
サイトワン セラピューティクス, インコーポレイテッド |
疼痛の処置のための11,13-修飾サキシトキシン:
|
|
JP2020515611A
(ja)
|
2017-03-29 |
2020-05-28 |
サイトワン セラピューティクス, インコーポレイテッド |
疼痛の処置のための11,13−修飾サキシトキシン
|
|
AU2018243749A1
(en)
|
2017-03-31 |
2019-11-21 |
Epizyme, Inc. |
Methods of using EHMT2 inhibitors
|
|
JP2020100564A
(ja)
|
2017-04-03 |
2020-07-02 |
京都薬品工業株式会社 |
リードスルー誘導剤およびその医薬用途
|
|
US11339144B2
(en)
|
2017-04-10 |
2022-05-24 |
Navitor Pharmaceuticals, Inc. |
Heteroaryl Rheb inhibitors and uses thereof
|
|
CN108689942B
(zh)
|
2017-04-11 |
2023-06-09 |
广东东阳光药业有限公司 |
含氮双环化合物及其制备方法和用途
|
|
KR20200011426A
(ko)
|
2017-04-20 |
2020-02-03 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
K-ras 조절인자
|
|
EP3612181A4
(en)
|
2017-04-21 |
2021-01-06 |
Epizyme, Inc. |
Combination therapies with ehmt2 inhibitors
|
|
EP3625214B1
(en)
|
2017-05-16 |
2022-07-06 |
Vertex Pharmaceuticals Incorporated |
Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels
|
|
CN107033149B
(zh)
|
2017-06-12 |
2020-01-03 |
上海交通大学 |
一种dpp-4酶抑制剂及其制备和应用
|
|
WO2018237194A1
(en)
|
2017-06-21 |
2018-12-27 |
Wave Life Sciences Ltd. |
Compounds, compositions and methods for synthesis
|
|
BR112020000553A2
(pt)
|
2017-07-11 |
2020-07-21 |
Vertex Pharmaceuticals Incorporated |
carboxamidas como moduladores de canal de sódio
|
|
CN109320509B
(zh)
|
2017-07-31 |
2022-02-08 |
轩竹生物科技股份有限公司 |
Fxr受体激动剂
|
|
CN109384712B
(zh)
|
2017-08-14 |
2021-05-07 |
北京宽厚医药科技有限公司 |
靶向nk1受体拮抗剂及其在化疗所致恶心、呕吐治疗中的应用
|
|
EP3668496A4
(en)
|
2017-08-17 |
2021-07-14 |
Ikena Oncology, Inc. |
AHR INHIBITORS AND THEIR USES
|
|
US11795162B2
(en)
|
2017-08-18 |
2023-10-24 |
Saint Louis University |
Modulators of the estrogen-related receptor
|
|
CN109553608B
(zh)
|
2017-09-26 |
2020-12-08 |
北京大学 |
一类五元六元杂环化合物及其制备方法和治疗肿瘤的用途
|
|
WO2019079596A1
(en)
|
2017-10-18 |
2019-04-25 |
Epizyme, Inc. |
METHODS OF USING EHMT2 INHIBITORS IN IMMUNOTHERAPIES
|
|
IL310625A
(en)
|
2017-10-18 |
2024-04-01 |
Epizyme Inc |
Methods of using ehmt2 inhibitors in treating or preventing blood disorders
|
|
EP3700527A4
(en)
|
2017-10-25 |
2021-03-10 |
Children's Medical Center Corporation |
PAPD5 INHIBITORS AND METHOD OF USING THEM
|
|
EP3479843A1
(en)
|
2017-11-01 |
2019-05-08 |
GenKyoTex Suisse SA |
Use of nox inhibitors for treatment of cancer
|
|
WO2019094732A1
(en)
|
2017-11-10 |
2019-05-16 |
Academia Sinica |
Inhibitors of cyclic-amp response element-binding protein
|
|
BR112020009729A2
(pt)
|
2017-11-15 |
2020-11-03 |
Metabomed Ltd. |
inibidores de acss2 e métodos de uso dos mesmos
|
|
KR20190076339A
(ko)
|
2017-12-22 |
2019-07-02 |
한미약품 주식회사 |
신규한 2,6-나프티리딘 2-옥시드 유도체 화합물 및 이의 용도
|
|
EP3502684A1
(en)
|
2017-12-22 |
2019-06-26 |
Universite De Bordeaux |
Method for metal ion detection in aqueous solutions using nucleolipid compounds
|
|
CN111315744B
(zh)
|
2018-01-09 |
2023-07-14 |
四川科伦博泰生物医药股份有限公司 |
杂芳基并四氢吡啶类化合物、其制备方法、药物组合物及应用
|
|
US11840527B2
(en)
|
2018-02-08 |
2023-12-12 |
Enyo Pharma |
Non-fused thiophene derivatives and their uses
|
|
US20190343817A1
(en)
|
2018-02-12 |
2019-11-14 |
Vertex Pharmaceuticals Incorporated |
Method of treating pain
|
|
WO2019195439A1
(en)
|
2018-04-05 |
2019-10-10 |
St. Jude Medical, Cardiology Division, Inc. |
High density electrode mapping catheter
|
|
EP3784754B1
(en)
|
2018-04-27 |
2022-06-08 |
Merck Patent GmbH |
Polymerisable liquid crystal material and polymerised liquid crystal film
|
|
WO2019206925A1
(en)
|
2018-04-27 |
2019-10-31 |
Merck Patent Gmbh |
Polymerisable liquid crystal material and polymerised liquid crystal film
|
|
US12258324B2
(en)
|
2018-05-16 |
2025-03-25 |
Lin Bioscience Pty Ltd. |
Fatty acid analogues and methods of use
|
|
TWI812739B
(zh)
|
2018-06-21 |
2023-08-21 |
景凱生物科技股份有限公司 |
Nadph氧化酶抑制劑、含其的醫藥組合物、及其應用
|
|
CA3105657A1
(en)
|
2018-07-09 |
2020-01-16 |
Lieber Institute, Inc. |
Pyridine carboxamide compounds for inhibiting nav1.8
|
|
EP3820860B1
(en)
|
2018-07-09 |
2025-10-15 |
Lieber Institute, Inc. |
Pyridazine compounds for inhibiting nav1.8
|
|
CN112638899B
(zh)
|
2018-08-01 |
2023-09-05 |
上海轶诺药业有限公司 |
一类具有免疫调节功能的芳香化合物的制备和应用
|
|
US11945803B2
(en)
|
2018-08-07 |
2024-04-02 |
Tosk, Inc. |
Modulators of RAS GTPase
|
|
WO2020034058A1
(en)
|
2018-08-13 |
2020-02-20 |
Rhodia Operations |
PROCESS FOR REDUCTIVE AMINATION OF α,β-UNSATURATED CARBONYL COMPOUND
|
|
WO2020034062A1
(en)
|
2018-08-13 |
2020-02-20 |
Rhodia Operations |
Process for the reductive amination of a carbonyl compound
|
|
CN113260609A
(zh)
|
2018-09-04 |
2021-08-13 |
美真达治疗公司 |
芳烃受体拮抗剂及其使用方法
|
|
WO2020069330A2
(en)
|
2018-09-28 |
2020-04-02 |
Acucela Inc. |
Inhibitors of vap-1
|
|
KR102092838B1
(ko)
|
2018-10-02 |
2020-03-24 |
성균관대학교산학협력단 |
신규 퓨란계 폴리카보네이트 및 이의 제조 방법
|
|
US12162886B2
(en)
|
2018-10-03 |
2024-12-10 |
Siteone Therapeutics, Inc. |
11,13-modified saxitoxins for the treatment of pain
|
|
TW202028183A
(zh)
|
2018-10-10 |
2020-08-01 |
大陸商江蘇豪森藥業集團有限公司 |
含氮雜芳類衍生物調節劑、其製備方法和應用
|
|
CA3113823A1
(en)
|
2018-10-15 |
2020-04-23 |
Dana-Farber Cancer Institute, Inc. |
Transcriptional enhanced associate domain (tead) transcription factor inhibitors and uses thereof
|
|
WO2020092187A1
(en)
|
2018-11-02 |
2020-05-07 |
Merck Sharp & Dohme Corp. |
2-amino-n-phenyl-nicotinamides as nav1.8 inhibitors
|
|
KR102860523B1
(ko)
|
2018-11-02 |
2025-09-16 |
머크 샤프 앤드 돔 엘엘씨 |
Nav1.8 억제제로서의 2-아미노-n-헤테로아릴-니코틴아미드
|
|
KR102151855B1
(ko)
|
2018-11-30 |
2020-09-03 |
롯데케미칼 주식회사 |
공액 디엔계 및 방향족 비닐계 공중합체의 제조 방법 및 이로부터 제조된 공액 디엔계 및 방향족 비닐계의 공중합체를 포함하는 타이어
|
|
US12246008B2
(en)
|
2018-12-05 |
2025-03-11 |
Merck Sharp & Dohme Llc |
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels
|
|
WO2020118036A1
(en)
|
2018-12-06 |
2020-06-11 |
The Children's Medical Center Corporation |
Antibacterial compounds and uses thereof
|
|
EP3894392A4
(en)
|
2018-12-11 |
2022-08-24 |
Duke University |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
|
|
AU2020205139A1
(en)
|
2019-01-04 |
2021-08-19 |
Jiangsu Hengrui Medicine Co., Ltd. |
6-oxo-1,6-dihydropyridazine derivative, preparation method therefor and medical use thereof
|
|
WO2020146612A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
US12441703B2
(en)
|
2019-01-10 |
2025-10-14 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
CN111434655A
(zh)
|
2019-01-15 |
2020-07-21 |
武汉朗来科技发展有限公司 |
溶血磷脂酸受体拮抗剂及其制备方法
|
|
CN113302262B
(zh)
|
2019-01-22 |
2025-01-17 |
默克专利股份有限公司 |
液晶聚合物膜的制备方法
|
|
CN112996774B
(zh)
|
2019-01-25 |
2022-11-22 |
江苏恒瑞医药股份有限公司 |
2-氧代-1,2-二氢吡啶类衍生物、其制备方法及其在医药上的应用
|
|
CA3127590A1
(en)
|
2019-01-28 |
2020-08-06 |
Mitochondria Emotion, Inc. |
Mitofusin activators and methods of use thereof
|
|
WO2020160225A1
(en)
|
2019-01-30 |
2020-08-06 |
Ohio State Innovation Foundation |
ESTROGEN RECEPTOR BETA (ERβ) AGONISTS FOR THE TREATMENT OF FIBROTIC CONDITIONS
|
|
WO2020191227A1
(en)
|
2019-03-20 |
2020-09-24 |
Cornell University |
Methods for controlling prostaglandin-mediated biological processes
|
|
WO2020191501A1
(en)
|
2019-03-27 |
2020-10-01 |
Algernon Pharmaceuticals Inc. |
Methods and uses of bemithyl and derivatives for treating lung disease, fatty liver disease, and kidney disorders
|
|
US12162834B2
(en)
|
2019-04-30 |
2024-12-10 |
Merck Patent Gmbh |
Reactive mesogens
|
|
US20220275009A1
(en)
|
2019-05-10 |
2022-09-01 |
Wacker Chemie Ag |
Cationic germanium(ii) compounds, process for preparing same, and their use as catalysts in hydrosilylation
|
|
KR20220024014A
(ko)
|
2019-05-14 |
2022-03-03 |
메타보메드 리미티드 |
Acss2 저해제 및 이의 사용 방법
|
|
WO2020251974A1
(en)
|
2019-06-10 |
2020-12-17 |
Kymera Therapeutics, Inc. |
Smarca inhibitors and uses thereof
|
|
WO2020254493A1
(en)
|
2019-06-21 |
2020-12-24 |
Bayer Aktiengesellschaft |
Thienylhydroxyisoxazolines and derivatives thereof
|
|
US20230103791A1
(en)
|
2019-06-27 |
2023-04-06 |
Glaxosmithkline Intellectual Property Development Limited |
2,3-dihydroquinazolin compounds as nav1.8 inhibitors
|
|
WO2021001739A1
(en)
|
2019-07-02 |
2021-01-07 |
Effector Therapeutics, Inc. |
Translational enhancers and related methods
|
|
CN112300069A
(zh)
|
2019-07-31 |
2021-02-02 |
明慧医药(上海)有限公司 |
一种选择性钠通道调节剂及其制备和应用
|
|
CN112300051A
(zh)
|
2019-07-31 |
2021-02-02 |
明慧医药(上海)有限公司 |
一种选择性钠通道调节剂及其制备和应用
|
|
WO2021032074A1
(zh)
|
2019-08-19 |
2021-02-25 |
江苏恒瑞医药股份有限公司 |
苯甲酰胺稠芳环类衍生物、其制备方法及其在医药上的应用
|
|
CN112390745B
(zh)
|
2019-08-19 |
2022-10-21 |
江苏恒瑞医药股份有限公司 |
吡啶烟酰胺类衍生物、其制备方法及其在医药上的应用
|
|
CN112409331B
(zh)
|
2019-08-21 |
2024-02-20 |
上海翰森生物医药科技有限公司 |
杂环类衍生物抑制剂、其制备方法和应用
|
|
CN112441969A
(zh)
|
2019-08-30 |
2021-03-05 |
明慧医药(上海)有限公司 |
一种选择性钠通道调节剂及其制备和应用
|
|
CN112479996B
(zh)
|
2019-09-12 |
2023-05-26 |
上海济煜医药科技有限公司 |
吡啶氮氧化合物及其制备方法和用途
|
|
CN114555577A
(zh)
|
2019-10-17 |
2022-05-27 |
埃尼奥制药公司 |
用于治疗门静脉炎症和纤维化的噻吩衍生物
|
|
AU2020397059A1
(en)
|
2019-12-06 |
2022-07-21 |
Vertex Pharmaceuticals Incorporated |
Substituted tetrahydrofurans as modulators of sodium channels
|
|
EP4079295A4
(en)
|
2019-12-20 |
2023-12-06 |
Samyang Holdings Corporation |
COMPOSITION HAVING IMPROVED SOLUBILITY AND BIOAVAILABILITY OF OLAPARIB
|
|
CN111217776A
(zh)
|
2020-01-19 |
2020-06-02 |
中国人民解放军军事科学院军事医学研究院 |
含苯并杂环结构的酰胺衍生物、组合物和应用
|
|
WO2021239117A1
(en)
|
2020-05-28 |
2021-12-02 |
Cullgen (Shanghai) , Inc. |
Modified proteins and protein degraders
|
|
CA3183948A1
(en)
|
2020-06-10 |
2021-12-16 |
Amgen Inc. |
Heteroalkyl dihydroquinoline sulfonamide compounds
|
|
JP7739051B2
(ja)
|
2020-06-10 |
2025-09-16 |
アムジエン・インコーポレーテツド |
シクロブチルジヒドロキノリンスルホンアミド化合物
|
|
JP2021195367A
(ja)
|
2020-06-10 |
2021-12-27 |
アムジエン・インコーポレーテツド |
シクロプロピルジヒドロキノリンスルホンアミド化合物
|
|
BR112022024476A2
(pt)
|
2020-06-17 |
2022-12-27 |
Merck Sharp & Dohme Llc |
5-oxopirrolidino-3-carboxamidas como inibidores de nav1.8
|
|
US12516046B2
(en)
|
2020-06-17 |
2026-01-06 |
Merck Sharp & Dohme Llc |
2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors
|
|
CR20220642A
(es)
|
2020-06-17 |
2023-02-15 |
Merck Sharp & Dohme Llc |
2-oxoimidazolidin-4-carboxamidas como inhibidores de nav1.8
|
|
GB202011996D0
(en)
|
2020-07-31 |
2020-09-16 |
Adorx Therapeutics Ltd |
Antagonist compounds
|
|
BR112023002659A2
(pt)
|
2020-08-14 |
2023-05-02 |
Siteone Therapeutics Inc |
Inibidores de cetona não hidratados de nav1.7 para o tratamento da dor
|
|
TW202214259A
(zh)
|
2020-08-19 |
2022-04-16 |
大陸商江蘇恆瑞醫藥股份有限公司 |
一種選擇性NaV抑制劑的前藥及其晶型
|
|
TW202220962A
(zh)
|
2020-08-19 |
2022-06-01 |
大陸商江蘇恒瑞醫藥股份有限公司 |
選擇性NaV抑制劑的結晶形式及其製備方法
|
|
CN111808019B
(zh)
|
2020-09-08 |
2020-11-27 |
上海济煜医药科技有限公司 |
一种并环化合物及其应用
|
|
KR20230070300A
(ko)
|
2020-09-24 |
2023-05-22 |
메르크 파텐트 게엠베하 |
중합성 액정 물질 및 중합된 액정 필름
|
|
WO2022070048A1
(en)
|
2020-09-29 |
2022-04-07 |
Cadila Healthcare Limited |
Novel amide derivatives
|
|
WO2022086986A1
(en)
|
2020-10-21 |
2022-04-28 |
Kura Oncology, Inc. |
Treatment of hematological malignancies with inhibitors of menin
|
|
CN112225695B
(zh)
|
2020-12-15 |
2021-03-02 |
上海济煜医药科技有限公司 |
一种氮氧化合物及其制备方法和用途
|
|
CN112457294B
(zh)
|
2021-01-27 |
2021-06-04 |
上海济煜医药科技有限公司 |
一种作为NaV1.8阻滞剂的化合物及其制备方法和用途
|
|
CN117794920A
(zh)
|
2021-06-04 |
2024-03-29 |
沃泰克斯药物股份有限公司 |
N-(羟烷基(杂)芳基)四氢呋喃甲酰胺作为钠通道调节剂
|